Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | News | November 5, 2014

CANOPY Supports CAS as an Alternative to CEA for Stroke Prevention in Standard Risk Patients

November 4, 2014—VIVA Physicians, Inc. announced that D. Christopher Metzger, MD, presented findings from the CANOPY trial during a late-breaking trials session at the VIVA 2014: Vascular InterVentional Advances meeting in Las Vegas, Nevada. CANOPY is a prospective, multicenter, nonrandomized, single-arm, postapproval study to evaluate the safety and effectiveness of the RX Acculink carotid stent system (Abbott Vascular) in patients at standard risk for adverse events from carotid endarterectomy (CEA). CANOPY was mandated by the US Food and Drug Administration as a follow-up study to the CREST trial.

Sponsored by Contego Medical, Inc.

evt | Article | November 2024 Supplement

Embracing a New Era: Putting Data Into Practice

Dr. Silver moderates a panel of experts who discuss their experiences with the Neuroguard IEP® System, insights into the data, device design characteristics, and impact on the field.

By Mitchell J. Silver, DO, FACC, FSVM, RPVI; Gary Ansel, MD; William A. Gray, MD, MSCAI, FACC; Elad I. Levy, MD, MBA; Sean P. Lyden, MD; S. Jay Mathews, MD, FACC, FSCAI; Robert Mendes, MD, FACS; D. Christopher Metzger, MD, FACC; Kenneth Rosenfield, MD, MHCDS; Adnan H. Siddiqui, MD, PhD; and Peter A. Soukas, MD

evt | News | November 2, 2015

Lutonix Global SFA Registry Results Show Safety and Efficacy for Bard's DCB

November 3, 2015—The 12-month and interim 24-month outcomes from the Lutonix Global SFA Registry were presented by D. Christopher Metzger, MD, during the second of two Late-Breaking Trials sessions at VIVA 15, the 13th annual Vascular InterVentional Advances meeting. The meeting, which is sponsored by VIVA Physicians, Inc., is being held November 2–5, 2015, at the Wynn Las Vegas in Las Vegas, Nevada. The session moderators are Michael R. Jaff, DO, and Krishna Rocha-Singh, MD.

evt | News | January 16, 2026

C-GUARDIANS Data Published for InspireMD’s CGuard Prime Carotid Stent

January 16, 2026—InspireMD, Inc., developer of the CGuard Prime carotid stent system for the prevention of stroke, announced that results from the company’s C-GUARDIANS pivotal trial have been published by D.

Advertisement

Advertisement

evt | News | November 2, 2015

Periprocedural Data Presented for 21,008 CAS Patients in Cordis' SAPPHIRE Worldwide Postapproval Registry

November 3, 2015—SAPPHIRE Worldwide is the largest prospective, multicenter, postapproval study to evaluate carotid artery stenting (CAS).

evt | News | May 28, 2024

InspireMD’s CGuard System Evaluated in C-GUARDIANS IDE Trial

May 28, 2024—InspireMD, Inc., developer of the CGuard embolic prevention stent system for the prevention of stroke, announced the presentation of 1-year outcomes from its C-GUARDIANS investigational device exemption (IDE) clinical trial of the CGuard carotid stent system for the treatment of carotid artery stenosis.

evt | News | November 1, 2023

InspireMD’s CGuard Carotid Stent System Evaluated at 30 Days in C-GUARDIANS Pivotal Trial

November 1, 2023—C-GUARDIANS is a pivotal FDA investigational device exemption trial designed to evaluate safety and efficacy of the neuroprotective CGuard carotid stent (InspireMD, Inc.) in treating symptomatic and asymptomatic patients with carotid stenosis at a high risk for carotid endarterectomy (CEA).

evt | News | June 24, 2025

InspireMD’s CGuard Prime Carotid Stent System Approved by FDA

June 24, 2025—InspireMD, Inc. announced that the FDA has granted premarket approval (PMA) of the company’s CGuard Prime carotid stent system in the United States.

evt | Article | October 2016

Ask the Experts: What SFA Trials Would You Most Like to See?

Experts discuss key questions to answer, potential trial designs, and the likelihood that the trials will be undertaken.

With Peter A. Schneider, MD; Thomas Zeller, MD; Osamu Iida, MD; Marianne Brodmann, MD; Krishna Rocha-Singh, MD; and Christopher Metzger, MD

evt | Article | June 2018

Creating CLI Teams

The VIVA Physicians' Vascular Leaders Forum offers guidance on core competencies and quality measures for establishing multidisciplinary CLI care teams.

By John H. Rundback, MD; Tony S. Das, MD; Peter A. Schneider, MD; and Michael R. Jaff, DO; on behalf of the VLF participants

evt | Article | November 2009

CMS and Carotid Artery Stenting

CMS's history with carotid and vertebral intervention, including the current status.

By Christopher J. White, MD


1

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button